Filing Details
- Accession Number:
- 0001209191-19-054575
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-10-30 21:09:41
- Reporting Period:
- 2019-10-29
- Accepted Time:
- 2019-10-30 21:09:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1551306 | Progyny Inc. | PGNY | Services-Misc Health & Allied Services, Nec (8090) | 272220139 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1789513 | Jennifer Bealer | C/O Progyny, Inc. 245 5Th Avenue New York NY 10016 | Evp, General Counsel | No | Yes | No | No |
Transaction Summary
Sold: | 36,761 shares | Avg. Price: $12.22 | Total Value: $449,219.42 |
Number of Shares After Transactions: | 18,239 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-10-29 | 36,761 | $12.22 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2019-10-30 | 18,239 | $0.91 | 18,239 | No | 4 | M | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | M | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2019-10-30 | 18,239 | $0.00 | 18,239 | $0.91 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
91,762 | 2027-11-09 | No | 4 | M | Direct |
Footnotes
- These shares were sold by the Reporting Person as a selling stockholder pursuant to an underwritten public offering by the Issuer. The reported sale price reflects the price at which the Reporting Person sold shares to the underwriters.
- One-fourth (1/4th) of the shares subject to the Option vested on October 30, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.